As of September 2024, Sinphar Pharmaceutical has a market cap of $168.55M. This makes Sinphar Pharmaceutical the world's 18346th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $169.60M | -4.57% |
2023 | $177.71M | 2.41% |
2022 | $173.53M | 14.71% |
2021 | $151.28M | -6.62% |
2020 | $162.01M | 59.54% |
2019 | $101.55M | 0.52% |
2018 | $101.03M | -10.85% |
2017 | $113.33M | -10.35% |
2016 | $126.42M | -12.03% |
2015 | $143.70M | -31.86% |
2014 | $210.89M | -8.21% |
2013 | $229.76M | 52.16% |
2012 | $151.00M | 35.85% |
2011 | $111.15M | -31.63% |
2010 | $162.58M | 14.68% |
2009 | $141.77M | 51.96% |
2008 | $93.29M | -21.69% |
2007 | $119.13M | 51.45% |
2006 | $78.66M | -11.54% |
2005 | $88.92M | 38.12% |
2004 | $64.38M | 13.87% |
2003 | $56.54M | 7.46% |
2002 | $52.61M | - |